😣
Facial Pain — Assessment & ManagementGCA prednisolone same-day · TN carbamazepine HLA-B*1502 · carotid dissection Horner 999 · Ludwig's angina 999 · TMD conservative management · dental abscess drainage · NPC urgent ENT referral (local pathway) · facial pain + persistent numbness → NG127 suspected cancer neuroimaging
Progress0 / 9

⚡ Snapshot. The whole pathway on one page: act now, triage, classify, treat today and safety-net. The Steps tab holds the detail.

Open full screen ↗
1
Safety

Red Flags — Malignancy, GCA & Vascular Emergency

Facial pain + progressive sensory loss or numbness over face (V1/V2/V3) without dental or sinus cause Trigeminal nerve compression by tumour (acoustic neuroma, meningioma, nasopharyngeal carcinoma, skull base metastasis). → Persistent facial numbness or abnormal neurological signs with facial pain require urgent neuroimaging via the suspected cancer pathway (NICE NG127). Do not assume dental or sinus disease without an adequate neurological assessment. The imaging protocol is determined by radiology/neurology/ENT.
Age 50+ with facial pain + jaw claudication (pain on chewing that stops with rest) or temporal artery tenderness Giant cell arteritis. → Start prednisolone 60 mg OD immediately (BSR 2020: 40–60 mg; 60 mg where there are ischaemic symptoms such as jaw claudication). Same-day fast-track GCA assessment; visual loss or amaurosis fugax → emergency/same-day ophthalmology or acute medical assessment (IV methylprednisolone may be required — via the specialist pathway). Obtain FBC, ESR, CRP, U&E, LFTs and glucose where this does not delay treatment; normal ESR or CRP does not exclude GCA. Temporal artery ultrasound promptly by an experienced service where available; biopsy where imaging is unavailable, inconclusive or the local pathway requires it. Neither investigation should delay corticosteroids.
Facial pain + any of diplopia, ptosis, proptosis, chemosis or visual loss, especially with fever or sinus/dental infection Cavernous sinus thrombosis or orbital apex syndrome (post-sinusitis or dental sepsis). → 999. Emergency hospital admission for imaging, ENT/ophthalmology/microbiology input, IV antibiotics and source control according to the local hospital protocol.
Painful red eye with blurred or reduced vision, haloes around lights, headache, nausea or vomiting (often a hazy cornea and a fixed, mid-dilated pupil) Acute angle-closure glaucoma — sight can be lost within hours. → Immediate same-day emergency ophthalmology (eye casualty or on-call ophthalmologist). Do not attribute to migraine or sinusitis; do not give dilating eye drops.
Sudden severe unilateral facial pain + ipsilateral Horner syndrome (ptosis + miosis + anhidrosis) + neck pain Carotid artery dissection. → 999. Urgent CTA/MRA and specialist stroke/vascular assessment. Antiplatelet or anticoagulation is decided by the receiving stroke/vascular team after imaging and assessment of intracranial complications — not started by the GP before imaging.
Facial pain + vesicular rash in dermatomal distribution (V1/V2/V3 or ear) Herpes zoster (shingles) — Ramsay Hunt syndrome if ear/pinna + facial palsy + hearing loss. → Aciclovir 800 mg 5x daily x 7 days within 72h (dose-adjust for renal impairment; consider valaciclovir if five-times-daily adherence is a problem). Herpes zoster ophthalmicus: same-day ophthalmology/urgent specialist advice, particularly with a red eye, visual symptoms or Hutchinson sign; low threshold for urgent assessment in other V1 rashes. Ramsay Hunt syndrome: same-day ENT assessment (often specialist antiviral plus corticosteroid). Do not routinely give systemic corticosteroids for uncomplicated shingles.
Floor-of-mouth swelling, trismus, dysphagia, drooling, voice change or airway concern after toothache Ludwig's angina — deep space dental infection with airway risk. → 999 transfer, senior airway/anaesthetic and maxillofacial/ENT involvement. Do not delay airway planning for imaging. IV antimicrobial therapy and surgical drainage follow the local deep-neck-space infection pathway. Can be rapidly fatal.
Giant cell arteritis presenting as facial or jaw pain is the most important vascular emergency in this differential — jaw claudication (pain on chewing that resolves with rest) is a specific ischaemic symptom of GCA, caused by ischaemia of the masseter and temporalis muscles from external carotid artery vasculitis. The medicolegal principle: a GP who attributes jaw pain in an elderly patient to 'dental' or 'TMJ' causes without checking ESR and CRP, and the patient subsequently develops GCA-related anterior ischaemic optic neuropathy with permanent blindness, faces a significant medicolegal claim. Prednisolone 40–60 mg (60 mg with ischaemic symptoms such as jaw claudication or visual symptoms) must be started immediately on clinical suspicion — before ultrasound or biopsy results are available. Normal inflammatory markers do not exclude GCA (NG127). Carotid artery dissection can present with ipsilateral facial pain (from pressure on sensory nerves around the internal carotid artery) plus Horner syndrome — this triad (facial pain + ipsilateral Horner + neck pain) is diagnostic until proved otherwise and is a 999 emergency.
2
Diagnose

Classification — Anatomical Framework

Dental and orofacial (most common)
Dental pain (pulpitis, periapical abscess, cracked tooth): localised, provoked by hot/cold/biting, may refer to ear/temporal area. Periodontal disease: dull ache, tender on biting, gum swelling. Dry socket (post-extraction day 3-5): severe pain, exposed bone, no blood clot. TMD (temporomandibular disorder): pre-auricular pain, jaw clicking, limited opening, worse with chewing, masseter/temporalis tenderness. Sialadenitis: submandibular/parotid swelling and pain, worse with eating, salivary stone.
Neuropathic facial pain
Trigeminal neuralgia (TN): electric shock-like lancinating pain, seconds only, triggered by light touch (V2/V3 most common), strict unilateral, no sensory loss between attacks. Persistent idiopathic facial pain (PIFP): constant, burning/aching, poorly localised, no trigger, no objective findings, significant psychological comorbidity. Post-herpetic neuralgia: burning/allodynia after shingles. Glossopharyngeal neuralgia (rare): severe lancinating throat/ear pain on swallowing.
Sinogenic and structural
Acute rhinosinusitis: cheek/frontal pressure, worse bending forward, nasal obstruction, recent URTI. Chronic rhinosinusitis: milder persistent pressure, post-nasal drip. Sinonasal malignancy: progressive unilateral facial numbness, loose teeth, epistaxis, trismus. Nasopharyngeal carcinoma (NPC): facial numbness + bloody nasal discharge + unilateral cervical lymphadenopathy.
Other causes
Parotitis (mumps, bacterial): parotid swelling, worse with eating. Cluster headache: severe periorbital pain + autonomic features (lacrimation, rhinorrhoea, Horner), strictly unilateral, attacks 15-180 minutes, up to 8/day in cluster period. Migraine (with facial component). Eagle syndrome (elongated styloid process — rare): throat/ear pain on swallowing.
Trigeminal neuralgia is one of the most severe pain conditions in clinical medicine — patients describe it as electric shock, lightning bolt, or hot poker applied to the face, lasting only seconds but occurring up to hundreds of times per day. The International Headache Society classification distinguishes classical TN (caused by neurovascular compression of the trigeminal nerve root — typically by the superior cerebellar artery), secondary TN (caused by MS, tumour, or AVM), and idiopathic TN (no cause found on MRI). In primary care, the key diagnostic features are: the paroxysmal quality (seconds, strictly not constant), the trigger phenomenon (light touch — toothbrushing, eating, cold air), the strict unilateral distribution, and the absence of objective sensory deficit between attacks. Any patient with features suggesting TN and objective sensory loss (numbness between attacks) needs urgent neuroimaging (NG127). Arrange or request MRI through the local neurology/ENT pathway, particularly for first presentation, atypical features, abnormal neurological findings, age under 40, bilateral TN or poor response to treatment, using a high-resolution trigeminal nerve protocol where available (EAN 2019).
3
Diagnose

Assessment — History, Examination & Investigations

Structured history
Character: sharp/stabbing/electric (neuropathic — TN, PHN), dull/aching/pressure (dental, TMD, sinusitis, GCA), burning (PIFP, PHN). Duration: seconds (TN, glossopharyngeal), minutes-hours (cluster, migraine, GCA jaw claudication), constant (dental abscess, PIFP, sinusitis, tumour). Triggers: light touch (TN), chewing/jaw use (TMD, GCA, salivary gland), hot/cold (pulpitis), bending forward (sinusitis), stress (TMD, PIFP). Distribution: specific nerve territory (TN, PHN), diffuse (PIFP), periorbital (cluster). Associated: nasal (sinusitis), ear (TMJ referred, Ramsay Hunt), neck pain (carotid dissection), jaw clicking (TMD). Remission: TN has pain-free intervals; PIFP is constant; GCA continuous.
Examination
TMJ: palpate pre-auricular, assess mouth opening (normal >35 mm), crepitus/click. Cranial nerves V (cotton wool + pin sensation in V1/V2/V3), VII (facial movement), VI (lateral gaze — cavernous sinus). Temporal arteries: tenderness, pulsation, thickening (GCA). Teeth: percussion test (periapical infection — tap each tooth, positive if disproportionately tender), cold test (pulpitis — prolonged pain >30s after cold application). Sinuses: percussion over maxillary and frontal. Skin: vesicles (shingles). Floor of mouth: bimanual palpation (salivary stone). Neck: lymphadenopathy, carotid tenderness.
Investigations
Guided by the clinical pattern, not a routine panel: FBC, ESR, CRP, U&E, LFTs, glucose (suspected GCA — age 50+ with new headache, jaw claudication or scalp/temporal symptoms; do not delay steroids; normal results do not exclude GCA) · OPG dental X-ray (via the dentist — periapical abscess, cyst, bony pathology) · CT sinuses (specialist — chronic rhinosinusitis, suspected sinonasal malignancy; not for acute sinusitis) · MRI (via the local neurology/ENT pathway for TN with first presentation or atypical features; suspected cancer pathway neuroimaging for persistent numbness or abnormal neurological signs, NG127) · Salivary USS (salivary stone, parotitis, parotid mass, when indicated)
The dental percussion test is one of the most clinically useful bedside investigations for facial pain in the orofacial region — gentle tapping on the crown of each upper or lower tooth with a metal object (pen top, dental mirror handle) identifies the specific tooth with periapical infection or pulpitis when the patient has jaw pain that cannot be clearly localised. The test is positive when the percussed tooth is significantly more painful than adjacent teeth. Combined with the cold test (ethyl chloride spray or ice applied briefly to the tooth — prolonged lingering pain beyond 30 seconds indicates irreversible pulpitis; no response indicates pulp necrosis suggesting periapical pathology), these two examinations identify dental causes in the majority of orofacial pain presentations. GPs should be confident performing these tests — they allow appropriate triage to emergency dental services and guide antibiotic prescribing when emergency dental access is unavailable. Document which tooth is affected and the clinical findings to facilitate handover to the dentist.
4
Diagnose

Trigeminal Neuralgia Diagnosis & TMD Assessment

TN — ICHD-3 diagnostic criteria
At least 3 attacks of unilateral facial pain fulfilling ALL of: one or more divisions of the trigeminal nerve; paroxysmal (fraction of a second to 2 minutes); severe intensity; electric shock/stabbing/sharp quality; precipitated by innocuous stimuli to the affected side. No radiation to other territories. No clinically evident neurological deficit between attacks. Atypical features needing urgent specialist assessment: persistent sensory loss, bilateral symptoms, age of onset under 40, optic neuritis or other features suggesting MS, abnormal neurological examination, hearing loss or other ear symptoms, pain between paroxysms, pain involving multiple cranial nerves, history of facial/oral malignancy or perineural spread. Arrange or request MRI through the local neurology/ENT pathway, particularly for first presentation, atypical features, abnormal neurological findings, age under 40, bilateral TN or poor response to treatment — high-resolution trigeminal nerve protocol where available (neurovascular contact, MS plaque, tumour).
TMD — diagnostic criteria (DC/TMD)
Myalgia (masticatory muscle pain): dull ache in masseter/temporalis region, worse with jaw use, reproduced by muscle palpation. Disc displacement with reduction: clicking/popping on jaw opening or closing that resolves with full opening. Arthralgia: TMJ pain on palpation + movement. Common, especially in women. TMD is heterogeneous — masticatory muscle pain, disc displacement, degenerative joint disease, trauma, inflammatory arthritis and central pain mechanisms. Contributors: bruxism (teeth clenching/grinding), psychological stress, widespread pain/fibromyalgia, sleep disorders. OPG: excludes dental/bony pathology. MRI TMJ only if surgery considered (specialist).
Cluster headache — key features to distinguish from facial pain
Strictly unilateral orbital/supraorbital/temporal pain, severe, lasting 15-180 minutes. Up to 8 attacks/day during a cluster period (typically 6-12 weeks, then months of remission). Ipsilateral autonomic features: lacrimation, conjunctival injection, rhinorrhoea, nasal congestion, eyelid oedema, ptosis, miosis, facial sweating. Restlessness (cannot lie still — unlike migraine). Circadian periodicity (attacks often at same time, frequently 01:00-03:00 AM). Acute treatment: oxygen and/or subcutaneous or nasal triptan (e.g. sumatriptan 6 mg SC) — 100% oxygen at at least 12 L/min through a non-rebreathing mask with reservoir bag, with home and ambulatory oxygen arranged (NICE CG150). Avoid oral triptans, opioids and simple analgesics for acute cluster headache.
The cluster headache oxygen treatment is frequently not prescribed or available in primary care — subcutaneous sumatriptan is a fast-acting acute treatment, and high-flow 100% oxygen (at least 12 L/min via a non-rebreathing mask with reservoir bag) is an effective alternative with no systemic side effects. NICE CG150 (headaches) recommends offering oxygen and/or a subcutaneous or nasal triptan for acute cluster headache, with home and ambulatory oxygen arranged where oxygen is used. In practice, oxygen prescribing for cluster headache is frequently not done in primary care — the GP needs to write an oxygen prescription (via a Home Oxygen Order Form to the regional home oxygen supplier) specifying: cluster headache, 100% O₂ at at least 12 L/min, non-rebreathing mask with reservoir bag, home and ambulatory supply. This should be done at the time of diagnosis to allow the patient to treat attacks at home, avoiding repeated A&E attendances.
5
Refer

Referral Pathways

999 / same-day emergency
Carotid dissection (facial pain + Horner + neck pain) → 999 · Painful red eye with reduced vision or haloes (acute angle-closure glaucoma) → immediate same-day emergency ophthalmology · Cavernous sinus thrombosis (proptosis + ophthalmoplegia + fever) → 999 · Proptosis, ophthalmoplegia, visual loss, chemosis and fever → 999 · Floor-of-mouth swelling, dysphagia, drooling, voice change or airway concern (Ludwig's angina) → 999 · Rapidly progressive facial swelling or systemic dental infection → same-day hospital/maxillofacial assessment · GCA + visual symptoms → same-day emergency ophthalmology/acute assessment + start prednisolone immediately
Start prednisolone same day
GCA clinically suspected (e.g. jaw claudication or temporal tenderness, age 50+) — same-day GCA pathway and immediate prednisolone; do not wait for ultrasound or biopsy results; normal ESR or CRP does not exclude GCA
Urgent referral (local pathway) · head and neck
Facial pain with persistent facial numbness or abnormal neurological signs → neuroimaging via the suspected cancer pathway (NICE NG127) · Unilateral facial pain with epistaxis, trismus, cervical lymphadenopathy or unexplained loose teeth · Trismus + unilateral nasal obstruction + epistaxis (sinonasal malignancy) · Parotid mass (salivary gland tumour) · NPC features (facial numbness + cervical lymphadenopathy + nasal discharge)
Neurology
If carbamazepine is ineffective, not tolerated or contraindicated → seek specialist advice and consider early referral to a specialist pain or condition-specific service (NICE CG173). Atypical TN features (sensory loss, bilateral, onset under 40, MS features, abnormal neurology, ear symptoms, pain between paroxysms, multiple cranial nerves, prior facial/oral malignancy) → urgent specialist assessment. MS-related TN → neurology. First or atypical cluster headache → specialist diagnostic review; complex/refractory cluster headache → referral.
Maxillofacial surgery
Persistent TMD with locking, severe restriction, trauma, inflammatory features or failure of conservative treatment · Salivary stone requiring surgical removal · Suspected temporomandibular joint arthritis on imaging
ENT
Chronic rhinosinusitis not responding to 3 months INCS + saline irrigation · Suspected sinonasal malignancy
Dentist (emergency or routine)
All dental causes — abscess, pulpitis, dry socket, TMD splint fitting, periodontal disease. Primary care is not a substitute for dental treatment — direct patients to a dentist or the NHS 111 dental pathway.
Primary-care management
Uncomplicated dental pain while arranging dental care · Uncomplicated acute sinusitis · Typical TN without red flags while awaiting the specialist/imaging pathway · Uncomplicated TMD · Post-herpetic neuralgia after excluding red flags · Persistent idiopathic facial pain after appropriate exclusion of structural disease
Nasopharyngeal carcinoma is a rare but important suspected head and neck cancer diagnosis that can present primarily as facial pain or numbness — it arises from the nasopharyngeal epithelium with strong EBV association and highest prevalence in Chinese, Southeast Asian, and North African populations. The triad: unilateral facial numbness (V2 distribution — maxillary nerve compression from skull base involvement), bloody nasal discharge or unilateral nasal obstruction, and unilateral upper cervical lymphadenopathy (cervical metastasis is common at diagnosis). NPC is radiosensitive and chemosensitive, and outcomes are better when it is diagnosed early. GPs should maintain a low threshold for an urgent ENT / head and neck referral in any patient of Chinese or Southeast Asian heritage with unexplained unilateral nasal symptoms, facial numbness, or cervical lymphadenopathy. NICE NG12 (updated April 2026) has no nasopharyngeal-specific criterion — its head and neck recommendations (for example, an unexplained neck lump aged 45 and over) apply where they are met (then use the suspected cancer pathway referral); otherwise, clinical judgement supports an urgent ENT referral through the local pathway.
6
Treat

Trigeminal Neuralgia — Treatment (NICE CG173: carbamazepine, then specialist advice)

First lineCarbamazepine 100 mg once or twice daily (NICE CG173 first-line) — increase gradually according to response and tolerability, review early, and titrate to the lowest effective dose (maximum per SPC). Before starting: FBC, LFTs, U&E/eGFR, serum sodium, weight/BMI, pregnancy considerations where relevant; HLA-B*1502 if Han Chinese or Thai ancestry, and consider in other relevant Southeast Asian groups (SPS; MHRA — SJS/TEN risk). After starting or changing dose: recheck sodium after about 2 weeks and then monthly for the first 3 months in patients at increased risk (older adults, CKD, diuretics or other sodium-lowering medicines), then according to clinical need; repeat FBC and LFTs periodically and if clinically indicated. Stop carbamazepine urgently and seek specialist advice if a rash develops, especially with mucosal involvement, fever or systemic symptoms; do not rechallenge after suspected SJS/TEN. Tell the patient to stop and seek same-day review for fever, sore throat, mouth ulcers, bruising or bleeding (possible blood disorder). Drug interactions: reduces OCP, warfarin efficacy.
If carbamazepine failsIf carbamazepine is ineffective, poorly tolerated or contraindicated, seek specialist advice and consider early referral to a specialist pain or condition-specific service (NICE CG173). Do not routinely initiate oxcarbazepine, lamotrigine, gabapentin or pregabalin for TN in primary care without specialist advice.
Specialist options (neurology / pain service)Oxcarbazepine, lamotrigine, gabapentin, pregabalin and other agents may be used by neurology/pain services in selected patients; the evidence is lower quality and does not supersede NICE's primary-care recommendation (EAN 2019).
Interventional (neurosurgery / pain clinic)Microvascular decompression (MVD): specialist option for classical TN with neurovascular compression on MRI. Percutaneous procedures (glycerol rhizotomy, balloon compression, radiofrequency thermocoagulation) — for patients unfit for craniotomy. Gamma Knife stereotactic radiosurgery — selected cases. Neurosurgical referral is a specialist decision when medical treatment fails or quality of life is severely impacted.
Response to carbamazepine is not sufficiently specific to confirm a TN diagnosis and may falsely reinforce an incorrect diagnosis — continue to look for atypical features and arrange MRI through the local pathway. The mechanism: carbamazepine blocks voltage-gated sodium channels in the trigeminal nerve, suppressing the ectopic firing that generates the paroxysmal pain. Key prescribing pitfalls: (1) always start at 100 mg once or twice daily and titrate slowly — starting too high causes nausea, dizziness, and diplopia that leads to unnecessary drug discontinuation; (2) check sodium after about 2 weeks and monthly for the first 3 months in those at increased risk (older adults, CKD, diuretics); (3) test HLA-B*1502 before prescribing in people of Han Chinese or Thai ancestry (consider in other relevant Southeast Asian groups) — the allele is strongly associated with carbamazepine-related SJS/TEN (MHRA); (4) routine six-monthly carbamazepine levels are not required.
7
Treat

Dental Abscess, Sinusitis & TMD Management

Dental abscess — antibiotic indications
Dental extraction or root canal is the definitive treatment — antibiotics alone without dental drainage are inadequate. Direct patients to a dentist or the NHS 111 dental pathway. Antibiotics are generally reserved for: spreading infection or cellulitis, systemic illness, significant trismus, high-risk immunocompromised patients, or inability to obtain immediate dental treatment where there is a risk of progression. If indicated: amoxicillin 500 mg TDS x 5 days; penicillin-allergic: metronidazole 400 mg TDS x 5 days (per current NICE/UKHSA guidance and local formulary). A patient with facial swelling, trismus, dysphagia, floor-of-mouth swelling, voice change, drooling or airway symptoms should not be managed with oral antibiotics alone — severe spreading odontogenic infection needs same-day maxillofacial or hospital assessment, with IV treatment per the local protocol. Analgesia: paracetamol + ibuprofen (check maximum paracetamol dose and liver risk; avoid NSAIDs in pregnancy, significant CKD, peptic ulcer disease, anticoagulation or high cardiovascular risk); do not use opioids routinely for uncomplicated dental pain.
Acute rhinosinusitis
Symptoms ≤10 days: do not offer antibiotics; give self-care advice and explain symptoms usually last 2–3 weeks. Symptoms ≥10 days without improvement: consider a high-dose intranasal corticosteroid for 14 days (adults and children 12 and over); offer no antibiotic or a back-up prescription depending on clinical features and risk — antibiotics make only a small difference to symptom duration. If an antibiotic is indicated (adults, NICE NG79): phenoxymethylpenicillin 500 mg QDS x 5 days; co-amoxiclav 500/125 mg TDS x 5 days if systemically very unwell, at high risk of complications or serious illness; penicillin allergy/intolerance: doxycycline or clarithromycin (erythromycin if a macrolide is needed in pregnancy) — check the local formulary. Refer to hospital: orbital/periorbital cellulitis, displaced globe, diplopia or ophthalmoplegia, reduced visual acuity, severe systemic infection, meningism, severe frontal headache or focal neurological signs. Symptomatic: saline nasal irrigation (Sterimar) + intranasal mometasone + paracetamol/ibuprofen. Topical decongestants: short-term only — a few days, no more than 5 consecutive days (MHRA Drug Safety Update, April 2026), as prolonged use causes rebound congestion. Chronic sinusitis: INCS + saline irrigation x 3 months then ENT.
TMD — conservative management
(1) Reassurance and education: often improves with conservative care; avoid clenching and wide mouth opening. (2) Soft diet: avoid hard/chewy foods, chewing gum. (3) Heat: warm flannel to masseter/temple 10 min 3x/day. (4) Jaw exercises: physiotherapy — stretching, coordination. (5) Analgesia: short course of simple analgesia/NSAID if appropriate. (6) Occlusal splint: dentist-fitted where indicated. Avoid: opioids, irreversible occlusal adjustments or extensive restorative dental procedures for TMD without specialist assessment; surgery only after other options have failed (NICE HTG352).
Post-herpetic neuralgia
Early antivirals reduce PHN risk: aciclovir 800 mg 5x/day x 7 days within 72h of rash (dose-adjust for renal impairment; valaciclovir if adherence is a problem). Established PHN (after excluding red flags): amitriptyline 10-25 mg ON; pregabalin 75-150 mg BD; gabapentin 300-600 mg TDS; topical lidocaine 5% plasters (Versatis); topical capsaicin 8% patch (specialist).

Next steps: see Trigeminal neuralgia · Giant cell arteritis · Sinusitis · Temporomandibular disorders · Shingles · Post-herpetic neuralgia

Combined paracetamol and ibuprofen is commonly more effective than either alone for acute dental pain (Moore et al., 2015, Cochrane Oral Health Group) where an NSAID is safe — check pregnancy, CKD, peptic ulcer disease, anticoagulation and cardiovascular risk, and the maximum paracetamol dose. Antibiotics do not treat dental pain and are reserved for spreading infection, systemic illness, significant trismus, high-risk immunocompromise or when immediate dental treatment is unavailable with risk of progression. This combination should be the first-line recommendation for dental pain awaiting treatment — prescribed as a regular (not PRN) schedule: paracetamol 1g every 6 hours + ibuprofen 400 mg every 8 hours (with food). The regular scheduling maintains plasma levels and prevents pain peaks, which is far more effective than taking analgesics after pain has re-emerged. This approach avoids unnecessary opioid prescribing for dental pain while the patient is directed to a dentist or the NHS 111 dental pathway.
8
Lifestyle

Jaw Health, Stress & Chronic Facial Pain Support

TMD and bruxism reduction Bruxism (teeth clenching/grinding) is a contributor to TMD, not the universal primary cause. Triggers: stress, anxiety, caffeine, alcohol, SSRIs, stimulants. Strategies: stress management (CBT, mindfulness), caffeine reduction, jaw awareness ("teeth apart" habit — lips together, teeth apart at rest except when chewing or speaking), occlusal splint at night. Botulinum toxin is specialist-only, with uncertain evidence and potential adverse effects. Physiotherapy referral for jaw exercises.
Soft diet during flares Soft diet during acute dental or TMD flares: yoghurt, soup, mashed potato, scrambled eggs, pasta, banana, smoothies, soft fish. Avoid hard/chewy foods (raw carrots, hard bread, steak, nuts, chewing gum) and wide jaw opening (corn on cob, large sandwiches). Maintain protein intake: eggs, tofu, cheese, yoghurt, soft fish. Duration: 2-4 weeks during acute flare, then gradual reintroduction.
Psychological support for chronic facial pain Persistent idiopathic facial pain is a diagnosis made after dental, ENT, neurological and structural causes have been appropriately excluded. Management should prioritise explanation, functional rehabilitation, psychological support and specialist or multidisciplinary pain input; medication may be considered according to the neuropathic pain phenotype and comorbidity. PIFP has a strong association with depression, anxiety, somatisation, and adverse life events — psychological treatment is as important as pharmacological. CBT: most evidence for chronic facial pain. NHS Talking Therapies referral (mild-moderate). Pain management programme (multidisciplinary) for severe PIFP affecting function. Acceptance and Commitment Therapy (ACT). Avoid repeated imaging once serious pathology has been appropriately excluded — but only after confirming that the original assessment was adequate.
Sleep and pain amplification Poor sleep amplifies pain through central sensitisation — patients with insomnia have significantly lower pain thresholds. Amitriptyline may be considered according to the neuropathic pain phenotype and comorbidity — it is not automatically indicated for every patient. Avoid benzodiazepines for sleep in facial pain. Sleep hygiene: consistent wake time, dark cool room, no screens 1h before bed, no caffeine after 2pm.
Oral hygiene and dental care Prevention of dental abscess: twice-daily brushing with fluoride toothpaste, daily interdental cleaning, 6-monthly dental check. Reduce sugary foods and acidic drinks (erosion + caries). NHS 111 dental pathway for urgent access when no dentist is available. Community dental services for housebound patients and those with learning disability.
GCA warning signs for at-risk patients All patients aged 50 and over presenting with new facial or jaw pain, headache, or scalp tenderness should receive GCA safety-netting: "If you develop pain in your jaw when chewing that stops with rest, new temporal headache, scalp tenderness when combing your hair, or any sudden visual change, seek emergency care immediately — do not wait." Document in clinical notes. Visual loss from GCA is permanent and occurs within hours of vessel occlusion — minutes matter.
Cluster headache management at home Offer oxygen and/or a subcutaneous or nasal triptan: home and ambulatory oxygen (100% O₂ at at least 12 L/min through a non-rebreathing mask with reservoir bag) via Home Oxygen Order Form (NICE CG150). Avoid oral triptans, opioids and simple analgesics for acute attacks. Cluster period prevention: verapamil — seek specialist advice if unfamiliar; baseline ECG, ECG after dose increases and periodically per the local headache protocol; watch for bradycardia, AV block and drug interactions. Avoid alcohol during active cluster period. First presentation should have specialist diagnostic review; complex/refractory cases require referral.
Analgesic overuse warning in facial pain Medication overuse headache (MOH): simple analgesics/non-opioids on ≥15 days/month for >3 months, or triptans, opioids or combination analgesics on ≥10 days/month for >3 months — the analgesics themselves cause rebound pain, creating a vicious cycle. MOH can transform episodic facial or head pain into chronic daily pain. Key advice: use acute analgesics on no more than 2-3 days/week. If already over-using: education, withdrawal of the overused medication, appropriate acute-treatment limits and headache prevention where indicated. Steroid bridging is not a standard primary-care intervention. Neurologist referral if complex.
The cluster headache home oxygen prescription is one of the most impactful but most frequently omitted interventions in UK primary care — patients with cluster headache typically attend A&E repeatedly during each cluster period because they have no effective treatment at home. High-flow oxygen (100% O₂ at at least 12 L/min via a non-rebreathing mask with reservoir bag) is effective for many cluster headache attacks and has no systemic side effects or drug interactions. NICE CG150 recommends offering oxygen, with home and ambulatory oxygen arranged. The oxygen is prescribed via the NHS Home Oxygen Service (Home Oxygen Order Form, available on NHS England website) specifying: indication (cluster headache), flow rate (at least 12 L/min), interface (non-rebreathing mask with reservoir bag), and that it is for acute use only (not continuous). Combined with a subcutaneous or nasal triptan, these treatments reduce the need for cluster headache A&E attendances.
9
Safety

Follow-Up & Safety-Netting

Trigeminal neuralgia monitoring
Review at 4-6 weeks: pain frequency/severity, carbamazepine side effects (nausea, dizziness, rash — stop urgently and seek specialist advice if rash, especially with mucosal involvement, fever or systemic symptoms). Sodium after about 2 weeks and monthly for the first 3 months in those at increased risk (older adults, CKD, diuretics), then by clinical need; FBC and LFTs periodically and if clinically indicated. MRI result review when available — secondary TN requires different management pathway. If carbamazepine is ineffective, poorly tolerated or contraindicated: specialist advice (NICE CG173). Consider a carbamazepine level only for suspected toxicity, poor adherence, loss of control, a pharmacokinetic interaction, pregnancy, organ failure or another specific indication.
GCA on prednisolone
Monitor clinical symptoms, visual symptoms, relapse features, steroid toxicity and inflammatory markers as part of the specialist/local GCA pathway — inflammatory markers should not be the sole basis for treatment decisions. Tapering is individualised and set by the specialist pathway (treatment commonly lasts 18–24 months); the GP is not responsible for a fixed taper schedule. Bone protection (calcium + vitamin D + bisphosphonate). Blood pressure, glucose or HbA1c and weight at baseline and at reviews.
Dental abscess review
If antibiotics given: review at 48-72h — systemic illness settling? Facial swelling reducing? Confirm patient has dental appointment. If spreading at any time, or not improving at 48h: same-day hospital assessment (IV antibiotics + surgical drainage).
TMD review
Review at 6-8 weeks: symptom improvement, splint fitted, lifestyle changes. If minimal improvement at 3 months conservative management: maxillofacial referral.
999 / Emergency
Carotid dissection (facial pain + Horner + neck pain) → 999 and CTA/stroke pathway · Proptosis, ophthalmoplegia, visual loss, chemosis and fever (cavernous sinus thrombosis) · Floor-of-mouth swelling, dysphagia, drooling, voice change or airway concern (Ludwig's angina) · GCA + visual disturbance (same-day emergency assessment, immediate steroids)
Urgent referral (local pathway)
Persistent facial numbness or facial pain with objective sensory loss/other neurological signs (NG127 suspected cancer neuroimaging) · Atypical or refractory TN · First or atypical cluster headache · Unilateral facial pain with epistaxis, trismus, cervical lymphadenopathy or unexplained loose teeth · Persistent TMD with locking, severe restriction, trauma or inflammatory features · Parotid mass · Trismus + nasal obstruction (sinonasal malignancy) · Persistent unexplained facial pain in over-40 after initial normal assessment
The safety-netting message for all patients aged 50 and over presenting with facial pain must include explicit GCA warning signs — even if GCA has been clinically excluded at the consultation, the safety-netting statement is essential: 'Because of your age, I want you to know that if you develop pain in your jaw on chewing that stops with rest, new temporal headache, scalp tenderness, or any sudden visual change in one eye, you should go to A&E immediately — do not wait for a GP appointment.' Document this safety-netting in the clinical record. Visual loss from GCA is permanent and can occur within hours — the safety-netting conversation and documentation takes 60 seconds and can preserve a patient's vision for decades. Where GCA is considered, document the reasoning, any ESR and CRP results (remembering that normal results do not exclude GCA) and the safety-net given.
Educational use only. Based on NICE NG127 Suspected neurological conditions: recognition and referral (facial pain with numbness/neurological signs), NICE CG150 Headaches (2012, updated June 2025), NICE CG173 Neuropathic pain (2013, updated 2020), ICHD-3 Trigeminal Neuralgia Criteria (international), BSR GCA guideline 2020, NICE NG79 Sinusitis: antimicrobial prescribing (2017), NICE/UKHSA/RCGP Summary of antimicrobial prescribing guidance (April 2025), European Academy of Neurology TN guideline (2019; doi:10.1111/ene.13950), SPS Carbamazepine monitoring, MHRA Drug Safety Update (carbamazepine/HLA-B*1502 skin reactions), EULAR imaging in large vessel vasculitis (2023 update), NICE TA518 (GCA), PCDS Herpes zoster guidance, NICE HTG352 (TMJ replacement; formerly IPG500), local antimicrobial and neuropathic pain guidelines, NICE NG12 Suspected Cancer (updated April 2026). Local specialist protocols (acute hospital, GCA fast-track, deep-neck-space infection) are distinguished from NICE recommendations.